Tctc Holdings, LLC Amgen Inc Transaction History

Tctc Holdings, LLC

  • $2.85 Billion
  • Q2 2024

A detailed history of Tctc Holdings, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tctc Holdings, LLC holds 35,074 shares of AMGN stock, worth $11.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
35,074
Previous 35,677 1.69%
Holding current value
$11.1 Million
Previous $10.1 Million 8.04%
% of portfolio
0.39%
Previous 0.34%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$262.75 - $319.31 $158,438 - $192,543
-603 Reduced 1.69%
35,074 $11 Million
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $18,014 - $21,745
-67 Reduced 0.19%
35,677 $10.1 Million
Q4 2023

Feb 08, 2024
SELL
$255.7 - $288.46 $473,812 - $534,516
-1,853 Reduced 4.93%
35,744 $10.3 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $74,341 - $92,296
-340 Reduced 0.9%
37,597 $10.1 Million
Q2 2023

Aug 10, 2023
SELL
$214.27 - $253.37 $404,970 - $478,869
-1,890 Reduced 4.75%
37,937 $8.42 Million
Q1 2023

May 12, 2023
SELL
$225.79 - $275.2 $141,118 - $172,000
-625 Reduced 1.55%
39,827 $9.63 Million
Q4 2022

Feb 10, 2023
SELL
$229.03 - $291.01 $1.15 Million - $1.46 Million
-5,018 Reduced 11.04%
40,452 $10.6 Million
Q3 2022

Nov 09, 2022
SELL
$224.46 - $253.15 $65,093 - $73,413
-290 Reduced 0.63%
45,470 $10.2 Million
Q2 2022

Aug 11, 2022
SELL
$230.71 - $256.74 $87,439 - $97,304
-379 Reduced 0.82%
45,760 $11.1 Million
Q1 2022

May 11, 2022
SELL
$219.27 - $242.57 $73,455 - $81,260
-335 Reduced 0.72%
46,139 $11.2 Million
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $1.17 Million - $1.34 Million
5,900 Added 14.54%
46,474 $10.5 Million
Q3 2021

Nov 04, 2021
SELL
$212.27 - $248.7 $84,908 - $99,480
-400 Reduced 0.98%
40,574 $8.63 Million
Q2 2021

Aug 11, 2021
BUY
$233.58 - $259.14 $5,605 - $6,219
24 Added 0.06%
40,974 $9.99 Million
Q1 2021

May 12, 2021
BUY
$221.91 - $258.6 $71,676 - $83,527
323 Added 0.8%
40,950 $10.2 Million
Q4 2020

Feb 10, 2021
BUY
$216.38 - $257.67 $175,700 - $209,228
812 Added 2.04%
40,627 $9.34 Million
Q3 2020

Nov 12, 2020
SELL
$234.65 - $260.95 $93,390 - $103,858
-398 Reduced 0.99%
39,815 $10.1 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $416,587 - $511,210
-2,106 Reduced 4.98%
40,213 $9.49 Million
Q1 2020

May 12, 2020
BUY
$182.24 - $241.7 $518,655 - $687,878
2,846 Added 7.21%
42,319 $8.58 Million
Q4 2019

Feb 11, 2020
SELL
$189.21 - $243.2 $87,982 - $113,088
-465 Reduced 1.16%
39,473 $9.52 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $184,556 - $221,137
-1,060 Reduced 2.59%
39,938 $7.73 Million
Q2 2019

Aug 14, 2019
BUY
$166.7 - $195.41 $432,919 - $507,479
2,597 Added 6.76%
40,998 $7.56 Million
Q1 2019

May 15, 2019
BUY
$180.87 - $203.88 $25,321 - $28,543
140 Added 0.37%
38,401 $7.3 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $27,652 - $32,278
-155 Reduced 0.4%
38,261 $7.45 Million
Q3 2018

Nov 14, 2018
SELL
$185.29 - $208.89 $73,745 - $83,138
-398 Reduced 1.03%
38,416 $7.96 Million
Q2 2018

Aug 14, 2018
BUY
$166.05 - $186.51 $137,987 - $154,989
831 Added 2.19%
38,814 $7.17 Million
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $87,256 - $101,970
515 Added 1.37%
37,983 $6.48 Million
Q4 2017

Feb 14, 2018
SELL
$168.79 - $188.59 $55,869 - $62,423
-331 Reduced 0.88%
37,468 $6.52 Million
Q3 2017

Nov 14, 2017
SELL
$167.29 - $191.0 $76,116 - $86,905
-455 Reduced 1.19%
37,799 $7.05 Million
Q2 2017

Aug 14, 2017
BUY
N/A
38,254
38,254 $6.59 Million

Others Institutions Holding AMGN

# of Institutions
3,073
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tctc Holdings, LLC Portfolio

Follow Tctc Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email